GROUP ONE TRADING, L.P. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is and the CUSIP is 88322Q958. A total of 5 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,015,452
-24.7%
360,700
+123.8%
0.01%
-23.1%
Q2 2023$4,004,208
+211.4%
161,200
+88.5%
0.01%
+160.0%
Q1 2023$1,285,920
-86.6%
85,500
-89.4%
0.01%
-77.3%
Q4 2022$9,574,019
+264.6%
809,300
+82.5%
0.02%
+340.0%
Q3 2022$2,626,000
+10.4%
443,500
-20.7%
0.01%
+25.0%
Q2 2022$2,378,000
-72.4%
559,600
-38.1%
0.00%
-55.6%
Q1 2022$8,604,000
-54.4%
904,700
-8.9%
0.01%
-40.0%
Q4 2021$18,861,000
-37.9%
992,700
+8.7%
0.02%
-54.5%
Q3 2021$30,391,000
-3.2%
913,200
+12.8%
0.03%
-13.2%
Q2 2021$31,401,000
-19.2%
809,500
+0.4%
0.04%
-34.5%
Q1 2021$38,859,000
-12.7%
806,200
-5.8%
0.06%
-24.7%
Q4 2020$44,498,000
+250.9%
855,400
+80.5%
0.08%
+92.5%
Q3 2020$12,682,000
+66.9%
473,900
+21.5%
0.04%
+14.3%
Q2 2020$7,599,000
+204.2%
390,100
+53.6%
0.04%
+75.0%
Q1 2020$2,498,000
+68.6%
253,900
+90.2%
0.02%
+100.0%
Q4 2019$1,482,000
+197.6%
133,500
+50.5%
0.01%
+150.0%
Q3 2019$498,000
-24.2%
88,700
+16.7%
0.00%
-33.3%
Q2 2019$657,000
+65.1%
76,000
+53.5%
0.01%
+50.0%
Q1 2019$398,000
-44.6%
49,500
-71.8%
0.00%
-33.3%
Q4 2018$719,000
-57.9%
175,300
-42.5%
0.01%
-53.8%
Q3 2018$1,708,000
-29.2%
305,000
+66.3%
0.01%
-38.1%
Q2 2018$2,412,000
-21.9%
183,400
-15.7%
0.02%
-32.3%
Q1 2018$3,089,000
+129.5%
217,500
+32.5%
0.03%
+244.4%
Q4 2017$1,346,000
+2.9%
164,100
+48.6%
0.01%
-25.0%
Q3 2017$1,308,000
-14.3%
110,400
-27.3%
0.01%
-25.0%
Q2 2017$1,527,000
-6.0%
151,900
+8.9%
0.02%
-15.8%
Q1 2017$1,625,000
+5918.5%
139,500
+2305.2%
0.02%
Q4 2016$27,000
-30.8%
5,800
+16.0%
0.00%
Q3 2016$39,0000.0%5,000
-23.1%
0.00%
Q2 2016$39,000
-63.6%
6,500
-48.0%
0.00%
-100.0%
Q1 2016$107,000
-84.2%
12,500
-78.0%
0.00%
-75.0%
Q4 2015$679,000
-41.0%
56,900
-50.1%
0.01%
-50.0%
Q3 2015$1,150,000
-3.7%
114,100
+58.5%
0.02%
-5.9%
Q2 2015$1,194,000
+13.7%
72,000
+6.2%
0.02%
+6.2%
Q1 2015$1,050,000
-12.9%
67,800
-10.9%
0.02%
-11.1%
Q4 2014$1,205,000
+193.2%
76,100
+97.7%
0.02%
+200.0%
Q3 2014$411,000
+311.0%
38,500
+263.2%
0.01%
+200.0%
Q2 2014$100,000
+104.1%
10,600
+49.3%
0.00%
+100.0%
Q1 2014$49,000
+145.0%
7,100
+42.0%
0.00%
Q4 2013$20,0005,0000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 12,500$107,0000.00%
View complete list of TG THERAPEUTICS INC shareholders